Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-24
    E.g., 2018-06-24


51061 items
4:41 PM, Jun 15, 2018  |  BC Extra | Politics & Policy

NIH pulls funding from compromised alcohol/CV health trial

NIH said it will stop funding the Moderate Alcohol and Cardiovascular Health (MACH) study after concluding that NIH employees violated agency policies to secure its funding and potentially biased its design towards the alcohol industry. Led...
4:28 PM, Jun 15, 2018  |  BC Extra | Clinical News

bluebird on track to submit MAA to EMA for LentiGlobin

bluebird bio Inc. (NASDAQ:BLUE) said it is on track to submit an MAA to EMA next half for its LentiGlobin BB305 to treat beta-thalassemia and reported additional data from three studies of the gene therapy....
3:59 PM, Jun 15, 2018  |  BC Extra | Politics & Policy

Massachusetts reauthorizes life science initiative

Massachusetts Gov. Charlie Baker signed into law Friday legislation that will invest up to $623 million in life science education, R&D and workforce training in the state. The legislation will provide $473 million in funding over...
3:49 PM, Jun 15, 2018  |  BC Extra | Preclinical News

ThinkCyte launches with AI-based high-throughput cell sorter

ThinkCyte Inc. (Tokyo, Japan) launched to develop an artificial intelligence-enabled, image-free visual cell sorting system that can sort cells by morphology at higher speeds and with greater accuracy than current methods. The company believes its...
3:45 PM, Jun 15, 2018  |  BC Extra | Politics & Policy

Healthcare products dropped from tariffs against China

Chinese healthcare products won't be subject to additional 25% U.S. import duties, according to the final list of 818 products released Friday by the Office of the U.S. Trade Representative. The tariffs, which have an...
3:27 PM, Jun 15, 2018  |  BC Extra | Politics & Policy

House committee to consider NIH raise

The House Appropriations Committee will consider a bill on Wednesday that calls for a $1.3 billion funding increase for NIH in FY19 over FY18, despite a Trump administration request to decrease the agency's funding by...
2:28 PM, Jun 15, 2018  |  BC Extra | Company News

BMS scores China's first immuno-oncology approval

The State Drug Administration approved Opdivo nivolumab from Bristol-Myers Squibb Co. (NYSE:BMY), marking China’s first approval of an immuno-oncology agent, according to the pharma. The anti-PD-1 mAb is indicated to treat locally advanced or metastatic...
1:47 PM, Jun 15, 2018  |  BC Extra | Clinical News

Global Blood down on 24-week sickle cell readout

Global Blood Therapeutics Inc. (NASDAQ:GBT) lost $7 (15%) to $40.05 on Friday after updated Phase IIa data in sickle cell disease patients showed that voxelotor (formerly GBT440) led to a lower hemoglobin response rate than...
1:32 PM, Jun 15, 2018  |  BC Extra | Financial News

Schmidt departing Cowen; Kersten joins Forbion

Eric Schmidt is leaving Cowen as managing director and senior research analyst to join an undisclosed private biotech as CFO. A 20-year veteran of the firm, Schmidt covered over 20 small-, mid- and large-cap biotechs....
1:12 PM, Jun 15, 2018  |  BC Extra | Company News

Management tracks: JHL, Aclaris, CytomX

Biosimilars company JHL Biotech Inc. (Zhubei, Taiwan) hired Ellis Chu as CFO. He was managing director and head of greater China at Ion Pacific Ltd., an Asia-focused venture capital merchant bank. Dermatology company Aclaris Therapeutics...